Does the use of N-acetylcysteine decrease the risk of contrast-induced nephropathy?

    loading  Checking for direct PDF access through Ovid

Abstract

EVIDENCE-BASED ANSWER

Probably. Although pooled data including low- and highdose regimens of N-acetylcysteine (NAC) in combination with a hydration protocol did not decrease risk of contrast-induced nephropathy (SOR: B, meta-analysis of heterogenous RCTs), doses of NAC of more than 600 mg every 12 hours decrease the risk of contrastinduced nephropathy in patients with baseline renal insufficiency (SOR: A, meta-analysis of RCTs).

Related Topics

    loading  Loading Related Articles